Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Duda

Showing results (1-10 of 338) with videos related to

Pageof 34
Sort By:
Roczniki Panstwowego Zakladu Higieny|January 1, 1997
[Report from the educational symposium on prophylaxis of civilization related diseases from food--nutrition--drugs]G Duda
Cancer Research|April 19, 2006
Antiangiogenesis and drug delivery to tumors: bench to bedside and backDan G Duda
ISRN Cell Biology|December 17, 2013
Molecular Biomarkers of Response to Antiangiogenic Therapy for CancerDan G Duda
The Keio Journal of Medicine|December 26, 2017
New Perspective on the Treatment of Intractable Gastrointestinal Cancers: Role of Combination TherapiesDan G Duda
Idrugs : the Investigational Drugs Journal|July 21, 2007
American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancerDan G Duda
The Keio Journal of Medicine|September 26, 2022
Targeting Tumor Microenvironment in Liver Cancers: Rationale, Current Progress, and Future PerspectiveDan G Duda
Aesthetic Plastic Surgery|January 1, 1994
The propeller flap: a one-stage procedure for nipple-areola reconstructionB Teimourian, G Duda
Journal of Biomedical Research|August 18, 2016
Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancerNisha Gupta, Dan G Duda
Ebiomedicine|February 5, 2020
Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigmsJiang Chen, Dan G Duda
Oncoimmunology|October 10, 2015
Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future developmentYunching Chen, Dan G Duda
Pageof 34

Showing results (1-10 of 338) with videos related to

Sort By:
Pageof 34
Roczniki Panstwowego Zakladu Higieny|January 1, 1997
[Report from the educational symposium on prophylaxis of civilization related diseases from food--nutrition--drugs]G Duda
Cancer Research|April 19, 2006
Antiangiogenesis and drug delivery to tumors: bench to bedside and backDan G Duda
ISRN Cell Biology|December 17, 2013
Molecular Biomarkers of Response to Antiangiogenic Therapy for CancerDan G Duda
The Keio Journal of Medicine|December 26, 2017
New Perspective on the Treatment of Intractable Gastrointestinal Cancers: Role of Combination TherapiesDan G Duda
Idrugs : the Investigational Drugs Journal|July 21, 2007
American Association for Cancer Research 98th Annual Meeting. Angiogenesis and anti-angiogenesis in cancerDan G Duda
The Keio Journal of Medicine|September 26, 2022
Targeting Tumor Microenvironment in Liver Cancers: Rationale, Current Progress, and Future PerspectiveDan G Duda
Aesthetic Plastic Surgery|January 1, 1994
The propeller flap: a one-stage procedure for nipple-areola reconstructionB Teimourian, G Duda
Journal of Biomedical Research|August 18, 2016
Role of stromal cell-derived factor 1α pathway in bone metastatic prostate cancerNisha Gupta, Dan G Duda
Ebiomedicine|February 5, 2020
Overcoming sorafenib treatment-resistance in hepatocellular carcinoma: A future perspective at a time of rapidly changing treatment paradigmsJiang Chen, Dan G Duda
Oncoimmunology|October 10, 2015
Targeting immunosuppression after standard sorafenib treatment to facilitate immune checkpoint blockade in hepatocellular carcinoma - an auto-commentary on clinical potential and future developmentYunching Chen, Dan G Duda
Pageof 34